None
Quote | 111 Inc. (NASDAQ:YI)
Last: | $1 |
---|---|
Change Percent: | -6.08% |
Open: | $1.0291 |
Close: | $1 |
High: | $1.13 |
Low: | $1 |
Volume: | 12,071 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
News | 111 Inc. (NASDAQ:YI)
2024-03-21 15:23:03 ET 111, Inc. (YI) Q4 2023 Earnings Conference Call March 21, 2024 07:30 ET Company Participants Junling Liu - Co-Founder, Chairman & Chief Executive Officer Luke Chen - Chief Financial Officer of 111's Major Subsidiary Conference Call Pa...
X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...
Message Board Posts | 111 Inc. (NASDAQ:YI)
Subject | By | Source | When |
---|---|---|---|
znewcar1: YI 36% v2,6M c3.23 f82,8M H3.49 ML1.63 | znewcar1 | investorshangout | 03/19/2022 12:47:48 AM |
Things looking up here after $5.01 bottom. | HoldEm777 | investorshub | 10/12/2021 7:16:20 PM |
znewcar1: YI 30% v2,54M c8.02 f82,8M H8.25 S a few days ago @5 | znewcar1 | investorshangout | 08/24/2021 8:43:28 PM |
Losing $20,000,000 million last quarter and a ($0.24) | make it happen | investorshub | 03/18/2021 12:13:45 PM |
Book Value Per Share (mrq) $2.49 | make it happen | investorshub | 03/18/2021 11:56:22 AM |
News, Short Squeeze, Breakout and More Instantly...
X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...
111, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results PR Newswire SHANGHAI , March 21, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting p...
111 to Announce Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results- Conference Call to Follow PR Newswire SHANGHAI , March 1, 2024 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company com...